Cargando…

Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry

Detalles Bibliográficos
Autores principales:	Valero, Marta, Sanchez-Piedra, Carlos, Freire, Mercedes, Colazo, Maria, Busquets, Noemi, Merino-Ibarra, Erardo, Rodriguez-Lozano, Carlos, Manrique, Sara, Campos, Cristina, Sanchez-Alonso, Fernando, Castrejon, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598974/ https://www.ncbi.nlm.nih.gov/pubmed/37880797 http://dx.doi.org/10.1186/s13075-023-03194-5

Ejemplares similares

Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
por: Valero, Marta, et al.
Publicado: (2023)

Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
por: Prior-Español, A., et al.
Publicado: (2021)

Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
por: Moreno-Ramos, Manuel José, et al.
Publicado: (2022)

Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
por: Moreno-Ramos, Manuel José, et al.
Publicado: (2022)

Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER
por: Bethencourt Baute, Juan José, et al.
Publicado: (2018)

Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register
por: Vela, Paloma, et al.
Publicado: (2020)

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER
por: Carmona, Loreto, et al.
Publicado: (2006)

Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
por: Álvaro-Gracia, José M, et al.
Publicado: (2023)

PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
por: Cohen, Jean-David, et al.
Publicado: (2012)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

Case series: Continued remission of PTSD symptoms after discontinuation of prazosin
por: Richardson, Christie, et al.
Publicado: (2023)

D-penicillamine-induced glomerulonephritis with crescent formation: Remission following drug discontinuation
por: Mokuda, S., et al.
Publicado: (2013)

SUN-383 Sustained Clinical Improvement after Discontinuation of Mifepristone: Unexpected Remission of Hypercortisolism
por: Anderson, Robin, et al.
Publicado: (2019)

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease
por: Gelbenegger, Georg, et al.
Publicado: (2022)

Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain
por: Mingot-Castellano, María-Eva, et al.
Publicado: (2017)

Nonlinear Stabilization Controller for the Boost Converter with a Constant Power Load in Both Continuous and Discontinuous Conduction Modes
por: Parada Salado, Juan Gerardo, et al.
Publicado: (2021)

Discontinuation of Scheduled Infliximab in Crohn’s Patients With Clinical Remission: A Retrospective Single-Center Study
por: Hu, Huiqin, et al.
Publicado: (2017)

Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
por: Han, Jae Joon
Publicado: (2023)

Neumonitis por metotrexato en paciente con enfermedad de Crohn, durante la pandemia COVID: un caso clínico inusual y revisión de la literatura
por: de los Mozos Ruano, Andrea, et al.
Publicado: (2021)

Methotrexate pneumonitis in a patient with Crohn’s disease, during the COVID pandemic: An unusual clinical case and review of the literature()
por: de los Mozos Ruano, Andrea, et al.
Publicado: (2021)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
por: Chaparro, María, et al.
Publicado: (2019)

Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis
por: Sakurai, Toshiharu, et al.
Publicado: (2020)

Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission
por: Kameda, Hideto, et al.
Publicado: (2021)

Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
por: Strand, Vibeke, et al.
Publicado: (2017)

Discontinuous Spirals of Stable Periodic Oscillations
por: Sack, Achim, et al.
Publicado: (2013)

Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide
por: Asimakopoulou, Athina, et al.
Publicado: (2014)

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
por: Tanaka, Yoshiya, et al.
Publicado: (2015)

Maintenance antipsychotic treatment versus discontinuation strategies following remission from first episode psychosis: systematic review
por: Thompson, Andrew, et al.
Publicado: (2018)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan
por: Yen, Ko, et al.
Publicado: (2022)

Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission
por: Jeong, Tae Jong, et al.
Publicado: (2022)

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission
por: Aoki, Yumi, et al.
Publicado: (2022)

Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
por: Kubo, Satoshi, et al.
Publicado: (2023)

Spontaneous Remission of Acute Myeloid Leukemia: A Case Report
por: Martínez-Díez, Yolanda, et al.
Publicado: (2022)

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
por: Bradley, Corey K., et al.
Publicado: (2019)

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
por: Dai, Cong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6rlsfksv0rfvaktieeck191si0